Pharmafile Logo
Pharmafocus logo
Advanced Search

Japanese companies merge to form Astellas

April 13, 2005
Sales and Marketing

News

Eloxatin and Campto gain new NICE approval

April 13, 2005
Sales and Marketing

NICE has recommended two more chemotherapy drugs for the first-line treatment of advanced colorectal cancer.The institute said that Sanofi-Aventis' Eloxatin …

News

Secrets of a youthful brand

April 12, 2005
Sales and Marketing Pan Advertising, Teva, lilly

 Today, more than ever before, the pharmaceutical industry is constantly being reminded that a blockbuster drug’s days are numbered and …

Feature

New depression treatment relieves sleep problems in patients

April 12, 2005
Sales and Marketing

An innovative new depression drug has shown improved benefits over existing treatments, according to data presented by its manufacturer Servier.Valdoxan …

News

The trials of the new PPRS

April 11, 2005

Feature

Serono hit by two late-stage failures

April 8, 2005
Research and Development, Sales and Marketing

Serono has halted development of a late-stage psoriasis drug and stopped another trial for a new skin cancer drug.Both drugs …

News

Bextra suspended from European and US markets

April 8, 2005
Sales and Marketing

News

‘Fundamental misconceptions’ in MP’s report, says industry

April 7, 2005

The ABPI has broadly welcomed the recommendations of the Health Select Committee's investigation into the pharmaceutical industry but has singled …

News

No salesforce purge in Pfizer’s $4 billion cuts

April 7, 2005
Sales and Marketing

Pfizer has set out a $4 billion cost cutting programme for the next three years in an attempt to return …

News

Industry issues warning as UK investment falls

April 6, 2005
Research and Development

News

New hepatitis B treatment approved in US

April 6, 2005
Sales and Marketing

Bristol-Myers Squibb has received US approval for its hepatitis B treatment Baraclude after a six-month priority review.Baraclude (entecavir) is BMS's …

News

Making academic research pay

April 6, 2005
Research and Development

Feature

Prescribing: a shift in the balance of power

April 5, 2005

Feature

Takeda abandons phase III diabetes drug

April 5, 2005
Research and Development

Takeda has been forced to abandon one of its lead pipeline products after a small number of patients in clinical …

News

Interactive sampling

April 4, 2005
Sales and Marketing

The internet has changed the way many of us live our lives, from grocery shopping to booking holidays, but can …

Feature

Government fails to meet GP recruitment target

March 31, 2005

The government has fallen short of recruiting its target number of new family doctors, despite figures showing an increase in …

News

Super surgeries spell big changes for patients and pharma

March 31, 2005

GPs will be given the freedom to carry out services traditionally only available in hospitals as the government unveiled plans …

News

And finally – the NSF for Long Term Conditions

March 31, 2005

The National Service Framework  for Long Term Conditions has been launched by the government, which has pledged that it will …

News

Renamed agency responds to pharma’s strategic aims

March 31, 2005
Medical Communications

Healthcare communications agency Brader Perryman has changed its name to Seven Stones, a move designed to reflect its diversity of …

News

Greater openness required by new European laws

March 31, 2005

Pharmaceutical companies will be obliged to share safety data more openly from November with the adoption of new pan-European laws.The …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026